Literature DB >> 35928005

Optimized protocols for RNA-induced silencing complex assembly and cleavage in cultured Drosophila cells.

Yajie Gao1, Yuanxiang Zhu2, Qinmiao Sun3, Dahua Chen4.   

Abstract

Here, we provide an optimized RNA-induced silencing complex (RISC) assembly and cleavage protocol in vitro without using radiolabeled RNA. The protocol is useful to characterize the biochemical properties of the RISC. We describe the preparation of RNA probes, the target RNA, and Drosophila cell lysates for RISC assembly assay. We then detail AGO1 complexes immunoprecipitation for RISC cleavage assay. This protocol can detect RISC assembly and cleavage products within 5 days. Moreover, it can detect 5'- and 3'-cleavage products simultaneously. For complete details on the use and execution of this protocol, please refer to Gao et al. (2022).
© 2022 The Authors.

Entities:  

Keywords:  Cell-based Assays; Gene Expression; Molecular Biology; Molecular/Chemical Probes; Protein Biochemistry

Mesh:

Substances:

Year:  2022        PMID: 35928005      PMCID: PMC9344023          DOI: 10.1016/j.xpro.2022.101596

Source DB:  PubMed          Journal:  STAR Protoc        ISSN: 2666-1667


Before you begin

Small interfering RNAs (siRNAs) and microRNAs (miRNAs) mediated gene silencing are a major process of gene expression at the transcriptional and post-transcriptional levels (Iwakawa and Tomari, 2022; Treiber et al., 2019). Small RNAs bind to Argonaute (AGO) proteins to form RISC to silence their target mRNA by RNA cleavage or by preventing protein translation (Bartel, 2018; Duchaine and Fabian, 2019). AGOs, as the catalytic core of RISC, play essential roles in mediating sequence-specific target gene silencing. To achieve their function for target gene silencing. siRNAs and miRNAs must form RISC with AGO proteins in a similar manner. RISC assembly is divided into two steps: the loading step and the maturation step. In the loading step, a small RNA duplex is loaded into the AGO protein to form the pre-RISC (Iwakawa and Tomari, 2022). In the maturation step, the duplex is separated, and only the guide strands reside in the AGO protein to form the mature RISC via wedging and passenger ejection (Kwak and Tomari, 2012). Mature siRNA-RISC induces the perfectly complementary target mRNA decay via cleavage activity, and mature miRNA-RISC generally causes the translational repression of partially complementary target mRNA. Further applications into therapeutics of RISC arise from the fact that siRNAs and miRNAs can be designed to target mRNA for silencing, and many factors can fine-tune the core silence activity of RISC. In vitro RISC assembly and cleavage assay provides powerful biochemical readouts to assess the activity and stability of RISC. Agarose native gel electrophoresis has been used to detect in vitro AGO-RISC assembly (Kawamata et al., 2009) and cleavage (Meister et al., 2004; Miyoshi et al., 2005) to investigate the molecular mechanism of RISC biogenesis in Drosophila AGO1 or human AGO2 pathways. However, previous protocols depended on radiolabeled RNA (Kawamata and Tomari, 2011) and required labeling and gel assay steps to be performed in an isotope lab. Here, we describe a similar agarose native gel electrophoresis system to analyze mature AGO-RISC assembly and cleavage without using radiolabeled RNA probes.

Preparation of the ASO for AGO1-RISC assembly

Timing: Approximately 2 days Anti-miR-9b antisense oligonucleotide (ASO) design and synthesis. Design anti-miR-9b ASO with 5′-FAM and 3′-2-O-methylated modification, complementary to miR-9b, except for one mismatch in the central region (Figure 1).
Figure 1

Schematic of the Anti-miR-9b antisense oligonucleotide

Schematic of the Anti-miR-9b antisense oligonucleotide This ASO is designed to have a central bulge to prevent endo-nucleolytic cleavage by AGO1-RISC. Other fluorescence modifications such as Cy3 or Cy5 would also work. CRITICAL: The RNA probe is very sensitive to the RNases. All the steps are conducted by using fresh RNase-Free water and RNase-Free pipet tips.

Preparation of the dsRNA

Timing: Approximately 1 day dsRNA synthesis (Figure 2).
Figure 2

Schematic of dsRNA synthesis

Preparation of the in vitro transcriptional template by PCR. Prepare DNA templates of dsRNAs from Drosophila cDNA with gene specific primers harboring the T7 promoter sequence. Gene specific primers used to prepare the templates are listed in key resources table. In vitro transcription reaction. Because the DNA templates used for synthesizing dsRNA contain the T7 promoter sequence at both 5′ and 3′ sides, the templates can be used to synthesize both sense and antisense RNA sequences by the T7 RiboMAX Express Large-Scale RNA Production Kit (Promega) according to the standard protocol. Sense and antisense RNAs are annealed to generate dsRNAs. Briefly microfuge the tube and collect the RNA solution at the bottom of the tube. Use the PCR program as follows to perform the annealing. dsRNA recovery and quantitation. Before the recovery procedure, perform DNase I treatment to remove the template DNA. Purify the dsRNAs following instructions of the T7 RiboMAX Express Large-Scale RNA Production Kit. These procedures remove the nucleotides, short oligonucleotides, proteins, and salts from dsRNAs. Quantitation can be determined by Nanodrop (Thermo Fisher Scientific). Store the dsRNA at −20°C or −80°C for up to one year. Schematic of dsRNA synthesis

Preparation of the agarose gel

Timing: Approximately 4 h Vertical agarose gel preparation. Clean and dry the glass plates to avoid the formation of air bubbles while pouring the gel. Assemble the glass plates and set them up in a standing (vertical) position with the gel casting equipment (Tanon). For a 102 × 85 × 1.5 mm plate, use 10 mL of TBE-agarose. Add 0.3 g agarose to 20 mL 0.5 × TBE solution in a 150 mL conical flask. Melt the agarose in a microwave oven until it is completely dissolved. Carefully and slowly pour the agarose into the glass plates, and immediately insert a 1.5 mm, 15-well comb between the glass plates. When the gel has solidified, carefully remove the comb. These gels should be stored at 4°C.

Preparation of substrate RNAs for the cleavage assay

Timing: Approximately 8 h Substrate RNAs preparation (Figure 3). See troubleshooting 2 and 4.
Figure 3

Schematic of cleavage substrate 1 preparation

Preparation of the transcriptional template by PCR. Synthesize the partially complementary oligonucleotides containing the miR-9b cleavage site as follows. miR-9b-S: 5′-GAACAATTGCTTTTACAGATGCACATATCGAGGTGAACATCACGTACGCATACAGCTAAAATCACCAAAGATCGGTTGGCAGAAGCTAT-3′. miR-9b-AS: 5′-GGCATAAAGAATTGAAGAGAGTTTTCACTGCATACGACGATTCTGTGATTTGTATTCAGCCCATATCGTTTCATAGCTTCTGCCAACCGA-3′. Use the miR-9b-S and miR-9b-AS oligonucleotides for a PCR fill-in reaction via the PCR program. PCR program: 60 s at 95°C, 5 min at 72°C, then cooling to 4°C. For the second PCR amplification reaction, directly add 2 μL of T7 and SP6 primer (10 μM) to the PCR mixture. Set up the following PCR program. Purify the PCR products after separation on a 1.5% agarose gel via gel DNA extraction according to the instructions. Ligate the PCR fragment into the pEASY cloning vector using the pEASY-Blunt Zero Cloning Kit. Perform sequencing using the M13 forward and reverse primers to verify positive colonies. Set up another PCR mixture using the template from a sequence-verified positive colony and use the PCR program from step (iv) above. The PCR products from this step will be used as the template for in vitro transcription. Capped transcription reaction for cleavage substrate 1 preparation. Assemble the capped in vitro transcription mixture at room temperature (22°C–28°C) according to the instruction of the mMESSAGE mMACHINE kit as follows. Mix thoroughly by gently pipetting the mixture up and down, and then briefly microfuge the tube and collect the solution at the bottom of the tube. Incubate at 37°C for 4 h or overnight (4–12 h). The mMESSAGE mMACHINE Kit is designed for optimal function with transcription templates in the 300–1,000 base range. In general, maximum yield can be achieved after a 2 h incubation. The second hour of incubation is necessary for transcription of < 300 base products. Add 1 μL TURBO DNase, mix well and incubate at 37°C for 15 min. Recover the RNA by lithium chloride precipitation according to the standard protocol. The RNA resulting from capped in vitro transcription provides the cleavage substrate 1 for the RISC cleavage assay. Cleavage substrate 2 preparation. Synthesize the 3′-RNA adaptor designed with both 5′-phosphate and 3′-6-FAM modification. 5′-phosphate-GrUrGrCrUrCrGrArGrUrCrGrCrGrGrCrCrGrCrArArGrGrArArCrArUrUrCrGrGrC-3′-6-FAM. Ligate the 3′-RNA adaptor to cleavage substrate 1 by T4 RNA ligase 1 following the manufacturer’s instructions as follows (Figure 4).
Figure 4

Schematic of cleavage substrate 2 preparation

Schematic of cleavage substrate 2 preparation Incubate at 25°C for 4 h. Purify the ligated RNA by size selection (> 200 nucleotides) using the Separated Fraction of the ZYMO-Spin Column, and use the purified ligated RNA for cleavage substrate 2 (Figure 5).
Figure 5

Purification and size selection of the cleavage substrate

CRITICAL: Avoid multiple freezes and thaw cycles for the RNA. Purification and size selection of the cleavage substrate Schematic of cleavage substrate 1 preparation

Preparation of buffers and solutions

Timing: Approximately 1 day Preparation of lysis buffer for RISC assembly lysate preparation. Refer to Materials and equipment. Preparation of the 5 × TBE solution. Refer to Materials and equipment. Preparation of the RISC assembly reaction mixture. Refer to Materials and equipment. Preparation of immunoprecipitation (IP) lysis buffer. Refer to Materials and equipment. Preparation of IP washing buffer. Refer to Materials and equipment. Preparation of cleavage reaction buffer. Refer to Materials and equipment.

Design qPCR primers for RNAi efficiency detection

Timing: Approximately 20 min Primers used in the protocol are listed in the key resources table.

Key resources table

Materials and equipment

Lysis buffer for RISC assembly lysates Store at 4°C for 6 months. Filtered buffer can be stored at 4°C for up to one year. 5 × TBE solution Store at room temperature (22°C–28°C) for up to 6 months. Filter buffer and avoid RNase contamination. RISC assembly reaction mixture Store aliquots at −80°C for up to one year. CRITICAL: DTT is a hazardous chemical. Carefully work under a chemical hood, and must wear gloves and a lab coat when handing. DTT waste needs to be collected and disposed of according to institute regulations. IP lysis buffer Store at 4°C for 6 months, and add DTT to a final concentration of 1 mM immediately before use. IP washing buffer Store at 4°C for 6 months. Cleavage reaction buffer Store aliquots at−80°C for up to one year. Distilled H2O treated with 0.1% diethylpyrocarbonate (DEPC) can be used instead of commercial RNase Free H2O.

Step-by-step method details

Production of S2 lysates for RISC assembly

Timing: 4 days This first part of the protocol is modified from a previous publication (Kawamata et al., 2009). This section describes how to prepare the cell lysates that will be used for RISC assembly assay. Preparation of Drosophila S2 cells. Culture Drosophila S2 cells in insect cell culture medium (Gibco) supplemented with penicillin-streptomycin and 10% FBS at 27°C. To keep a healthy S2 cell culture going, the passage numbers of S2 cell is limited in 10–15. Dilute confluent cells (∼1 × 107 cells/mL) and seed at a density of 5 × 105 cells/mL. dsRNA treatment. Seed S2 cells into a 10 cm dish with volumes of 10 mL at a density of 1 × 105 cells/mL and prepare for RNAi. Thaw the frozen dsRNA reagents and place them on ice. Add 8 μg dsRNA for targetting each gene(dcr-2, r2d2, ago2, or ago1 (3′-UTR)) to the cell culture medium and shake gently. Transfer 1 mL of cells from the 10 cm dish to a 12-well plate to detect the efficiency of RNAi knockdown. See troubleshooting 1. Plasmid transfection. After 24 h of dsRNA treatment, prepare for plasmid transfection. Preheat the Lipofectamine 2000 and Opti-MEM at room temperature (22°C–28°C). Add 8 μg pAc5.1-Flag-AGO1 and 5 μg of pAc5.1-miR-9b plasmids to 500 μL Opti-MEM, and vortex the mixture. The transfection of the miRNA is not essential. It depends on the expression levels of miRNA in the cell line. Add 20 μL Lipofectamine 2000 to 500 μL Opti-MEM, and vortex the mixture. Add diluted plasmids to the diluted Lipofectamine 2000 mixture. Vortex the mixture, and incubate at room temperature (22°C–28°C) for 15 min. Add the plasmid-lipid complex dropwise to the cell medium of the 10 cm dish and shake gently to mix. qRT-PCR to confirm the efficiency of RNAi knockdown. Design primers to perform the qPCR. Primers used for qPCR are listed in the key resources table. After 72 h of dsRNA treatment, collect cells for subsequent real-time PCR. Extract total RNA from the S2 cells treated with dsRNAs by the Trizol method. Prepare cDNA with the HiScript III Reverse Kit (Vazyme) according to the instructions and dilute to a volume of 100 μL. Set up the qRT-PCR reaction system. Run the real-time PCR instrument. Calculate the efficiency of RNAi knockdown. The relative mRNA expression is determined using the formula: 2-Ct method (Schmittgen and Livak, 2008) (Figure 6). See troubleshooting 1.
Figure 6

Relative expression levels of indicated genes in S2 cells treated with dsRNA measured by qRT-PCR

(A–D) S2 cells were treated with dsRNAs against dcr-2 (A), r2d2 (B), ago1 (C) or ago2 (D). Three days post dsRNA treatment, expressions of indicated genes were analyzed by qRT-PCR analysis. The two-tailed Student's t test was used to analyze statistical variance. Error bars indicate mean ± s.d (n=3). ∗∗∗, p<0.001, ∗∗∗∗, p<0.0001.

The TaqMan probes can be used instead of SYBR Green mixture and oligonucleotides. Relative expression levels of indicated genes in S2 cells treated with dsRNA measured by qRT-PCR (A–D) S2 cells were treated with dsRNAs against dcr-2 (A), r2d2 (B), ago1 (C) or ago2 (D). Three days post dsRNA treatment, expressions of indicated genes were analyzed by qRT-PCR analysis. The two-tailed Student's t test was used to analyze statistical variance. Error bars indicate mean ± s.d (n=3). ∗∗∗, p<0.001, ∗∗∗∗, p<0.0001. Preparation of cell lysates. After 48 h of transfection, collect the transfected S2 cells by centrifugation at 500 g for 5 min at 4°C, and then wash cells with cold PBS twice. The waste of cell culture medium and the PBS needs to be collected and thoroughly mixed with an appropriate amount of 84 disinfectants, then disposed of according to institute regulations. Resuspend cells in 1 mL lysis buffer (freshly supplemented with 2 mM DTT and protease inhibitor cocktail) and transfer to a pre-chilled Dounce homogenizer. Dissolve one Complete EDTA-free protease inhibitor tablet in 500 μL lysis buffer as 100× stock solutions. Prepare freshly before use. Prepare homogenates by performing 50 strokes using the tight pestle. CRITICAL: This step should be performed on ice. CRITICAL: Between samples, clean the Douncer and pestle with lysis buffer 3 times to avoid cross-contamination between different samples. Clear the lysates by centrifugation at 15,000 g for 15 min at 4°C. Transfer the supernatant and aliquot 50 μL/tube. Freeze the lysates using liquid nitrogen and store them at −80°C. We recommend immediately starting the AGO-RISC assembly reaction using fresh lysates. Instead of the lysates prepared from S2 cells overexpressing AGO1, and in which dcr-2, r2d2, ago2, and ago1 are knocked down, the lysates prepared from the embryo of dcr-2 mutant flies can be used (Lee et al., 2004). CRITICAL: Avoid multiple freezes and thaw cycles. Pause point: The lysates can be stored at −80°C for up to one month.

Native gel analysis of AGO1-RISC assembly

Timing: 4 h This section describes how to perform the in vitro RISC assembly. Before beginning the in vitro RISC assembly, set up the agarose gel in the electrophoresis tank and fill it with pre-chilled 0.5 × TBE buffer. Cooling the electrophoresis buffer is critical to detect complexes in the AGO1-RISC assembly. It is optimal to perform the electrophoresis at 4°C. Prepare the in vitro RISC assembly as follows. Incubate the mixture at 27°C for 40 min. See troubleshooting 3. Load 3 μL of the assembly products into the 1.5% agarose native gel. See troubleshooting 5. CRITICAL: Washing the gel and the gel wells with 0.5 × TBE buffer before running is essential for a good resolution. Load 3 μL of 2 × RNA loading dye and perform electrophoresis at 300 V in cold 0.5 × TBE buffer for 20 min. CRITICAL: We have noticed that the RISC assembly sample will not rapidly load to the bottom of the wells, likely due to the RISC assembly mixture not containing glycerol. We load the sample using long pipet pips to sink the sample to the bottom of the wells. End the electrophoresis, and keep the gel attached to the glass plate. Perform phosphor imaging to detect the mature AGO1-RISC.

Immunoprecipitation of AGO1 complexes for cleavage assay

Timing: 8–12 h This section details the associated procedures of immunoprecipitation of AGO1 complexes. This part of the protocol is critical since the immunoprecipitation of AGO1 complexes will be used for the RISC cleavage assay. Perform the cell culture as described under production of S2 lysates for RISC assembly. Preparation of the cell lysates. Harvest S2 cells by centrifugation at 500 g for 5 min. Wash cells two times with cold PBS. Add 1 mL of lysis buffer per 10 cm dish, resuspend the cell pellet by pipetting to ensure cells are fully lysed, and incubate on ice for 10 min. Centrifuge at 12,000 g for 15 min at 4°C. Carefully transfer the supernatant to new tubes and aliquot a 30 μL sample as the input fraction for western blot analysis. When we transfer supernatant, do not disturb the pellets. CRITICAL: Buffers should be pre-chilled on ice, and the centrifuge should be pre-cooled to 4°C. Immunoprecipitation. For immunoprecipitation of endogenous AGO1, incubate the supernatants with anti-AGO1 antibody or control IgG by rotation at 4°C for 5 h or overnight (6–12 h). Use 20 μL of protein A/G agarose beads per sample. Wash the beads once with 1 mL lysis buffer. Add the washed beads to the lysates and incubate at 4°C for 3 h on a rotator. Wash the samples three times with washing buffer. Transfer the beads to a fresh tube and take an aliquot of 5 μL beads as the immunoprecipitation fraction for western blot analysis. CRITICAL: All steps should be performed on ice or at 4°C.

RISC cleavage assay

Timing: 5 h The section of this protocol is modified from a previous publication (Miyoshi et al., 2005), and this section describes how to perform the RISC cleavage assay in vitro. Remove the supernatant. Prepare the in vitro RISC cleavage reaction mixture as follows. Incubate at 27°C for 2 h. Add 1 mL of Trizol reagent to the cleavage RNA sample and pipet the sample up and down several times to homogenize. Incubate for 10 min to allow complete dissociation of the AGO1-RNA complex. Add 0.2 mL of chloroform to 1 mL of Trizol, cap the tube and mix thoroughly by shaking. Incubate at room temperature (22°C–28°C) for 5 min. CRITICAL: Trizol reagent and chloroform are hazardous solutions. Carefully work under a fume hood, must wear gloves and a lab coat. Trizol and chloroform waste must be collected and disposed of according to institute regulations. Centrifuge the sample for 15 min at 13,000 g at 4°C. Transfer 0.5 mL of the aqueous phase to a new tube. After centrifugation, three phases will be obtained. An upper aqueous phase contains RNA, interphase contains DNA, and a lower phase contains proteins. Carefully pipet the aqueous phase and avoid transferring the interphase into the pipette. Add 0.5 mL of 100% ethanol to the aqueous phase and mix well. Proceed with the RNA Clean-up protocol of the ZYMO-Spin column. Subject the cleaved fragment of substrate 1 to the Qsep1 for size distribution analysis, and the cleaved fragment of substrate 2 to gel electrophoresis analysis. Agilent bioanalyzer (Agilent 2100 Bioanalyzer) with the Agilent RNA Pico Kit (Cat # 5067-1513RUO) can be used instead of Qsep1.

Expected outcomes

Here, we provide an optional protocol to detect AGO1-RISC assembly and cleavage by fluorescent labeling of RNA instead of radiolabeling. We use a FAM-ASO that is complementary to the miR-9b guide strand to detect the mature AGO1-RISC (Figures 7A and 7B). Moreover, we prepare FAM-labeled RNA substrate by T4 RNA ligation and perform the cleavage assay (Figures 7C–7E).
Figure 7

In vitro RISC assembly and cleavage assay

(A) Schematic of AGO-RNA-induced silencing complex assembly.

(B) The lysates from transfected S2 cells treated with dsRNA targeting dcr-2, ago2, r2d2, and ago1 (Figure 6) were incubated with 5′-FAM-labeled and 3′-2′-O-methylated anti-miR-9b ASO complementary to the guide strand of miR-9b for 40 min. Then the complexes were analyzed by native gel electrophoresis.

(C) Schematic of the cleavage assay procedure. The AGO complexes purified by immunoprecipitation cleaved the RNA substrate at a defined position.

(D and E) The AGO1 was immunoprecipitated by anti-AGO1 protein A/G beads from S2 cell lysates and incubated with cleavage substrate 1 or 2 containing a sequence complementary to miR-9b. The cleaved fragment was detected by gel electrophoresis (D) and Qsep1 (E).∗Indicates the signal corresponding to the cleaved substrate.

In vitro RISC assembly and cleavage assay (A) Schematic of AGO-RNA-induced silencing complex assembly. (B) The lysates from transfected S2 cells treated with dsRNA targeting dcr-2, ago2, r2d2, and ago1 (Figure 6) were incubated with 5′-FAM-labeled and 3′-2′-O-methylated anti-miR-9b ASO complementary to the guide strand of miR-9b for 40 min. Then the complexes were analyzed by native gel electrophoresis. (C) Schematic of the cleavage assay procedure. The AGO complexes purified by immunoprecipitation cleaved the RNA substrate at a defined position. (D and E) The AGO1 was immunoprecipitated by anti-AGO1 protein A/G beads from S2 cell lysates and incubated with cleavage substrate 1 or 2 containing a sequence complementary to miR-9b. The cleaved fragment was detected by gel electrophoresis (D) and Qsep1 (E).∗Indicates the signal corresponding to the cleaved substrate.

Limitations

Because this method labels the target RNA of RISC in the in vitro RISC assembly reaction, only the mature AGO1-RISC is detected. This protocol is not applicable to analyzing the dynamic formation of AGO1-RISC complexes. The sensitivity of fluorescent labeling is lower than that of radiolabeling.

Troubleshooting

Problem 1

Low RNAi knockdown efficiency (steps 2 and 4).

Potential solution

Increase the amount of dsRNA used for RNAi. Seed the S2 cells at a lower density. After dsRNA treatment, treat the S2 cells by starvation using a medium without serum for 30 min.

Problem 2

Low yield of the cleavage RNA substrate (step of preparation of substrate RNAs for the cleavage assay). Increase the reaction time to 4 h or overnight (6–12 h). Increase the amount of template DNA.

Problem 3

There is no signal for AGO1-RISC present in the agarose gel (step 8). Check the amount and quality of the miR-9b ASO on an agarose gel to ensure it is intact and of the expected size. Extend the reaction time. The reaction temperature can also be adjusted. The temperature is critical for the formation and stability of mature AGO1-RISC complexes.

Problem 4

RNA degradation (step of preparation of substrate RNAs for the cleavage assay). RNA is highly sensitive to RNases. To avoid RNase contamination, the pipettes, pipette boxes and tube racks are treated with RNase, RNA and DNA Remover (Vazyme); Use the RNase-free 1.5 mL tubes, pipette tips, and H2O even though the buffer or reagent contains RNase inhibitors, the probability of degradation increases with time and temperature. To preserve RNA quality and avoid degradation, keep everything cold and spend no more than 60 min for RNA recovery.

Problem 5

Images of the RISC assembly contain high background (step 9). The time of in vitro RISC assembly and the loading volumes of the products should be tested. The background might be reduced by a different loading volume or a longer reaction time.

Resource availability

Lead contact

Further information and requests for resources and reagents should be directed to and will be fulfilled by the lead contact, Dr. Dahua Chen (chendh@ynu.edu.cn).

Materials availability

All unique materials generated from this study are available from the lead contact with a complete Materials Transfer Agreement.
StepsTemperatureTimeCycles
Denaturation94°C2 min1
Annealing94°C–22°C0.1°C/s1
Incubation22°C5 min1
ReagentAmount
10 μM miR-9b-S1 μL
10 μM miR-9b-AS1 μL
2 × Phanta Mixture25 μL
ddH2ON/A
Total46 μL
StepsTemperatureTimeCycles
Initial denaturation95°C2 min1
Denaturation95°C15 s30 cycles
Annealing56°C15 s
Extension72°C30 s
Final extension72°C3 min1
Hold4°Cforever
ReagentAmount
10 μM T7 Primer2 μL
10 μM SP6 Primer2 μL
2 × Phanta Mixture25 μL
ddH2ON/A
Total50 μL
ComponentAmount
2 × NTP/CAP10 μL
10 × Reaction buffer2 μL
Template DNA∼ 200 ng
Nuclease-free H2ON/A
Total20 μL
ComponentAmount
Cleavage substrate 120 pmol
3′RNA adaptor40 pmol
10 × T4 RNA ligase buffer2 μL
10 mM ATP2 μL
50% PEG 80007 μL
RNase inhibitor (40 U/μL)1 μL
T4 RNA ligase I1 μL
Nuclease-free H2ON/A
Total20 μL
REAGENT or RESOURCESOURCEIDENTIFIER
Antibodies

Rabbit polyclonal anti-dmAGO1. Working dilution: 1:2000AbcamCat# ab5070; RRID: AB_2277644
Rabbit polyclonal anti-Flag. Working dilution: 1:3000Sigma-AldrichCat# SAB1306078; RRID: N/D
Mouse monoclonal anti-β-Tubulin. Working dilution: 1:1000CowinCat# CW0098M; RRID: AB_2814800

Bacterial and virus strains

E. coli DH5αAlpaLifeCat# KTSM101L

Chemicals, peptides, and recombinant proteins

2 × Phanta Max Master MixVazymeCat# P525-01
Protein A/G agarose beadsThermo Fisher ScientificCat# 21186
Lipofectamine 2000Thermo Fisher ScientificCat# 11668019
HEPESThermo Fisher ScientificCat# 11344041
KOHAladdinCat# P11287-500g
KACAladdinCat# P108329-500g
Nonidet P-40Thermo Fisher ScientificCat# 28324
GlycerolThermo Fisher ScientificCat# 17904
RNase Free H2OSolarbioCat# R1600
cOmplete Protease Inhibitor CocktailRocheCat# 4693116001
Triton X-100SigmaCat# X-100
Tween 20SigmaCat# P1379
PageRuler Prestained Protein Ladder, 10–180 kDaThermo Fisher ScientificCat# 26616
AgaroseInvitrogenCat# 16500500
EDTA (Ethylenediaminetetraacetic acid)SigmaCat# 798681
TrizolTIANGENCat# DP424
SYBR qPCR Master MixVazymeCat# Q711
T4 RNA ligase INEBCat# M0437M
RNase inhibitorNEBCat# M0314L
RNA Loading DyeNEBCat# B0363S
ssRNA LadderNEBCat# N0364S
Schneider’s Drosophila MediumGibcoCat# 11720-067
Opti-MEMGibcoCat# 31985088
Tris BaseSigma-AldrichCat# 11814273001
Boric AcidSigma-AldrichCat# B0394
PBSThermo Fisher ScientificCat# 14190144
DTTThermo Fisher ScientificCat# P2325
Creatine PhosphateSigma-AldrichCat# 237911
Creatine phosphokinaseSigma-AldrichCat# C3755
ATPThermo Fisher ScientificCat# R0441
GTPThermo Fisher ScientificCat# R0461
ddH2ON/AN/A
Liquid nitrogenN/AN/A

Critical commercial assays

FasePure Gel DNA Extraction KitVazymeCat# DC301-01
pEASY-Blunt Zero Cloning KitTransGen BiotechCat# CB501-01
T7 RiboMAX Express Large-Scale RNA Production KitPromegaCat# P1700
HiScript III Reverse TranscriptaseVazymeCat#R302
mMESSAGE mMACHINE kitThermo Fisher ScientificCat# AM1344
RNA clean and Concentrator-5Zymo ResearchCat# R1013
RNase, RNA and DNA RemoverVazymeCat# R504

Deposited data

Raw and analyzed dataMendeleyhttps://data.mendeley.com/datasets/4gmsw3t82z/1

Experimental models: Cell lines

D. melanogaster cell line S2(Xia et al., 2010)N/A

Oligonucleotides

T7 primer(Gao et al., 2022)5′-TAATACGACTCACTATAGAACAATTGCTTTTACAG-3′
SP6 primer(Gao et al., 2022)5′-ATTTAGGTGACACTATAGGCATAAAGAATTGAAGA-3′
dsRNA(gfp) Forward Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAatggtgagcaagggc-3′
dsRNA(gfp) Reverse Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAggtgcgctcctggac-3′
dsRNA(ago1-3′UTR) Forward Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAaaagtatcgcccctccc-3′
dsRNA(ago1-3′UTR) Reverse Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAtttcctatttgctttcaatt-3′
dsRNA(ago2) Forward Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAagccaaggccaataccaa-3′
dsRNA(ago2) Reverse Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAcagaccgaccagggc-3′
dsRNA(dcr-2) Forward Primer(Gao et al., 2022)5′-CTCACTATAGGGAGActacgcagcttccatagc-3′
dsRNA(dcr-2) Reverse Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAggcattaccgtcccga-3′
dsRNA(r2d2) Forward Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAatggataacaagtcagccgt-3′
dsRNA(r2d2) Reverse Primer(Gao et al., 2022)5′-CTCACTATAGGGAGAttcaatggccgctcgc-3′
RT-rp49 Forward Primer(Gao et al., 2022)5′-ATGACCATCCGCCCAGCATAC-3′
RT- rp49 Reverse Primer(Gao et al., 2022)5′-CTGCATGAGCAGGACCTCCAG-3′
RT-Ago2 Forward Primer(Gao et al., 2022)5′-TCCAGGGCACGGCCAAGCCA-3′
RT-Ago2 Reverse Primer(Gao et al., 2022)5′-CGATTGCAACGAGGGAACAT-3′
RT-r2d2 Forward Primer(Gao et al., 2022)5′-AGGCATTGCGCAGAAAGAAA-3′
RT-r2d2 Reverse Primer(Gao et al., 2022)5′-GCAAGGGAACCAACGATGAA-3′
RT-Ago1 Forward Primer(Gao et al., 2022)5′-GGAGATCAAGGGTTTGAAGATCG-3′
RT-Ago1 Reverse Primer(Gao et al., 2022)5′-AGTGGGAATGATTGCATCTGAG-3′
RT-dcr2 Forward Primer(Gao et al., 2022)5′-TCTAGCCTTGTGGCGAGAAA-3′
RT-dcr2 Reverse Primer(Gao et al., 2022)5′-GCCTCAAGGGTATCGGCTAT-3′
3′-RNA adaptor(Gao et al., 2022)5′-phosphate-GrUrGrCrUrCrGrArGrUrCrGrCrGrGrCrCrGrCrArArGrGrArArCrArUrUrCrGrGrC-3′-6-FAM.
miR-9b-S(Gao et al., 2022)5′-GAACAATTGCTTTTACAGATGCACATATCGAGGTGAACATCACGTACGCATACAGCTAAAATCACCAAAGATCGGTTGGCAGAAGCTAT-3′
miR-9b-AS(Gao et al., 2022)5′-GGCATAAAGAATTGAAGAGAGTTTTCACTGCATACGACGATTCTGTGATTTGTATTCAGCCCATATCGTTTCATAGCTTCTGCCAACCGA-3′

Recombinant DNA

pAc5.1-Flag-AGO1(Gao et al., 2022)https://doi.org/10.1016/j.molcel.2022.02.035
pAc5.1-Flag-EGFP(Gao et al., 2022)https://doi.org/10.1016/j.molcel.2022.02.035
pAc5.1-miR 9b(Gao et al., 2022)https://doi.org/10.1016/j.molcel.2022.02.035

Software and algorithms

ImageJ(Schneider et al., 2012)https://imagej.nih.gov/ij/download.html
Snap geneSnapGenehttps://www.snapgene.com/try-snapgene/

Other

Dounce homogenizer (with tight pestle)WHEATONCat# 1984-10002
Eppendorf centrifugeEppendorfCat# 5427R
Eppendorf centrifugeEppendorfCat# 5910R
Cold roomN/AN/A
Membrane filter, pore size 0.22 mMilliporeCat# GSWP04700
Casting UnitTanonCat# 180-1600&1808
NanoDropThermo ScientificCat# ND-ONE-W
LightCycler®480 Real-time PCRRocheN/A
Qsep1-liteBiOpticCat# C100001-L
Tanon-6600 imaging workstationTanonN/A

Lysis buffer for RISC assembly lysates

ReagentFinal concentrationAmount
HEPES-KOH (pH 7.4)30 mM1.4298 g
KAC100 mM1.9628 g
Mg(AC)25 mM0.1424 g
ddH2ON/AN/A
TotalN/A200 mL

Store at 4°C for 6 months. Filtered buffer can be stored at 4°C for up to one year.

5 × TBE solution

ReagentFinal concentrationAmount
Tris base445 mM56.3 g
Boric acid445 mM27.6 g
EDTA10 mM3.7 g
ddH2ON/AN/A
TotalN/A1000 mL

Store at room temperature (22°C–28°C) for up to 6 months. Filter buffer and avoid RNase contamination.

RISC assembly reaction mixture

ReagentFinal concentrationAmount
KAC133.3 mM16 μL of 1 M stock
ATP3.33 mM4 μL of 100 mM stock
DTT30 mM2 μL of 1 M stock
Creatine monophosphate83.3 mM20 μL of 500 mM stock
Creatine phosphokinase0.1 U/μL6 μL of 2 U/μL stock
RNase Free H2ON/A72 μL
TotalN/A120 μL

Store aliquots at −80°C for up to one year.

IP lysis buffer

ReagentFinal concentrationAmount
Tris-HCl (pH 7.4)50 mM3.028 g
KCl300 mM11.183g
EDTA2 mM0.372 g
Nonidet P-400.5%5 mL
Glycerol10%50 mL
ddH2ON/AN/A
TotalN/A500 mL

Store at 4°C for 6 months, and add DTT to a final concentration of 1 mM immediately before use.

IP washing buffer

ReagentFinal concentrationAmount
Tris-HCl (pH 7.4)50 mM3.028 g
NaCl300 mM8.766 g
MgCl25 mM0.238 g
Nonidet P-400.05%0.5 mL
ddH2ON/AN/A
TotalN/A500 mL

Store at 4°C for 6 months.

Cleavage reaction buffer

ReagentFinal concentrationAmount
HEPES150 mM18 μL of 1 M stock
KCl200 mM24 μL of 1 M stock
ATP3.33 mM4 μL of 100 mM stock
DTT10 mM1.2 μL of 1 M stock
MgCl225 mM6 μL of 0.5 M stock
RNase Free H2ON/A66.8 μL
TotalN/A120 μL

Store aliquots at−80°C for up to one year.

ReagentAmount
2 × SYBR Green Master Mix10 μL
100 μM RT-Forward Primer0.1 μL
100 μM RT-Reverse Primer0.1 μL
cDNA template9.8 μL
Total20 μL
StepsTemperatureTimeCycles
Initial denaturation95°C30 s1
Denaturation95°C10 s40 cycles
Annealing/ Extension60°C30 s
Melting curve95°C5 s1
65°C60 s
97°C5 s
Cooling4030 s1
ReagentAmount
RISC Assembly mixture3 μL
S2 cell lysates4 μL
50 nM miR-9b ASO1 μL
RNase inhibitor0.5 μL
RNase-free H2O1.5 μL
Total10 μL
ReagentAmount
Cleavage reaction mixture5 μL
Protein A/G Beads +/- Immunoprecipitated AGO110 μL
Cleavage substrate 1 or 2100 ng
RNase inhibitor1 μL
RNase-free H2ON/A
Total25 μL
  14 in total

1.  The N domain of Argonaute drives duplex unwinding during RISC assembly.

Authors:  Pieter Bas Kwak; Yukihide Tomari
Journal:  Nat Struct Mol Biol       Date:  2012-01-10       Impact factor: 15.369

2.  Analyzing real-time PCR data by the comparative C(T) method.

Authors:  Thomas D Schmittgen; Kenneth J Livak
Journal:  Nat Protoc       Date:  2008       Impact factor: 13.491

Review 3.  Mechanistic Insights into MicroRNA-Mediated Gene Silencing.

Authors:  Thomas F Duchaine; Marc R Fabian
Journal:  Cold Spring Harb Perspect Biol       Date:  2019-03-01       Impact factor: 10.005

Review 4.  Metazoan MicroRNAs.

Authors:  David P Bartel
Journal:  Cell       Date:  2018-03-22       Impact factor: 41.582

5.  Slicer function of Drosophila Argonautes and its involvement in RISC formation.

Authors:  Keita Miyoshi; Hiroko Tsukumo; Tomoko Nagami; Haruhiko Siomi; Mikiko C Siomi
Journal:  Genes Dev       Date:  2005-11-14       Impact factor: 11.361

6.  The Fused/Smurf complex controls the fate of Drosophila germline stem cells by generating a gradient BMP response.

Authors:  Laixin Xia; Shunji Jia; Shoujun Huang; Hailong Wang; Yuanxiang Zhu; Yanjun Mu; Lijuan Kan; Wenjing Zheng; Di Wu; Xiaoming Li; Qinmiao Sun; Anming Meng; Dahua Chen
Journal:  Cell       Date:  2010-12-10       Impact factor: 41.582

7.  Native gel analysis for RISC assembly.

Authors:  Tomoko Kawamata; Yukihide Tomari
Journal:  Methods Mol Biol       Date:  2011

8.  Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs.

Authors:  Gunter Meister; Markus Landthaler; Agnieszka Patkaniowska; Yair Dorsett; Grace Teng; Thomas Tuschl
Journal:  Mol Cell       Date:  2004-07-23       Impact factor: 17.970

9.  Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways.

Authors:  Young Sik Lee; Kenji Nakahara; John W Pham; Kevin Kim; Zhengying He; Erik J Sontheimer; Richard W Carthew
Journal:  Cell       Date:  2004-04-02       Impact factor: 41.582

10.  Lipid-mediated phase separation of AGO proteins on the ER controls nascent-peptide ubiquitination.

Authors:  Yajie Gao; Yuanxiang Zhu; Hailong Wang; Ying Cheng; Dongbo Zhao; Qinmiao Sun; Dahua Chen
Journal:  Mol Cell       Date:  2022-03-23       Impact factor: 17.970

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.